Posted on 12/17/2009
Paula Cofer, FDA Patient Representative, served on the April 25, 2008 FDA Ophthalmic Devices Panel in Gaithersburg, MD. The meeting was called to discuss issues concerning post-market experiences with LASIK.
Ms. Cofer expressed several concerns about the safety and long-term consequences of LASIK, and asked for changes to the labeling of excimer lasers.
Read some of Ms. Cofer’s statements, which are found in the April 25, 2008 panel meeting transcript: Click here